 A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
 C CARDIOVASCULAR SYSTEM
|
C01 CARDIAC THERAPY
|
C01A CARDIAC GLYCOSIDES
|
C01B ANTIARRHYTHMICS, CLASS I AND III
|
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
|
C01CA Adrenergic and dopaminergic agents
|
C01CA01 Etilefrine [DG:DG00210]
|
C01CA02 Isoprenaline [DG:DG00211]
|
 D08090 Isoprenaline (INN)
D01390 Isoproterenol hydrochloride (USP) <JP/US>
D02066 Isoproterenol sulfate (USP)
D02150 l-Isoprenaline hydrochloride (JP18) <JP>
|
C01CA03 Norepinephrine [DG:DG00212]
|
C01CA04 Dopamine [DG:DG00213]
|
C01CA05 Norfenefrine [DG:DG00214]
|
C01CA06 Phenylephrine [DG:DG00215]
|
C01CA07 Dobutamine [DG:DG00216]
|
C01CA08 Oxedrine [DG:DG00217]
|
C01CA09 Metaraminol [DG:DG00218]
|
C01CA10 Methoxamine [DG:DG00219]
|
C01CA11 Mephentermine [DG:DG00220]
|
C01CA12 Dimetofrine
|
C01CA13 Prenalterol [DG:DG00221]
|
C01CA14 Dopexamine [DG:DG00222]
|
C01CA15 Gepefrine
|
C01CA16 Ibopamine [DG:DG00223]
|
C01CA17 Midodrine [DG:DG00224]
|
C01CA18 Octopamine [DG:DG00225]
|
C01CA19 Fenoldopam [DG:DG00226]
|
C01CA21 Cafedrine
|
C01CA22 Arbutamine
|
C01CA23 Theodrenaline
|
C01CA24 Epinephrine [DG:DG00013]
|
C01CA25 Amezinium metilsulfate
|
C01CA26 Ephedrine [DG:DG00227]
|
C01CA27 Droxidopa
|
C01CA28 Centhaquine [DG:DG03144]
|
C01CA30 Combinations
|
C01CA51 Etilefrine, combinations
|
C01CE Phosphodiesterase inhibitors
|
C01CX Other cardiac stimulants
|
C01D VASODILATORS USED IN CARDIAC DISEASES
|
C01E OTHER CARDIAC PREPARATIONS
|
C02 ANTIHYPERTENSIVES
|
C03 DIURETICS
|
C04 PERIPHERAL VASODILATORS
|
C05 VASOPROTECTIVES
|
C07 BETA BLOCKING AGENTS
|
C08 CALCIUM CHANNEL BLOCKERS
|
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
C10 LIPID MODIFYING AGENTS
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
R01 NASAL PREPARATIONS
|
R02 THROAT PREPARATIONS
|
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
R03A ADRENERGICS, INHALANTS
|
R03AA Alpha- and beta-adrenoreceptor agonists
|
R03AB Non-selective beta-adrenoreceptor agonists
|
R03AB02 Isoprenaline [DG:DG00211]
|
D08090 Isoprenaline (INN)
D01390 Isoproterenol hydrochloride (USP) <JP/US>
D02066 Isoproterenol sulfate (USP)
D02150 l-Isoprenaline hydrochloride (JP18) <JP>
|
R03AB03 Orciprenaline [DG:DG01044]
|
R03AC Selective beta-2-adrenoreceptor agonists
|
R03AH Combinations of adrenergics
|
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
|
R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
|
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
|
R03C ADRENERGICS FOR SYSTEMIC USE
|
R03CA Alpha- and beta-adrenoreceptor agonists
|
R03CB Non-selective beta-adrenoreceptor agonists
|
R03CB01 Isoprenaline [DG:DG00211]
|
D08090 Isoprenaline (INN)
D01390 Isoproterenol hydrochloride (USP) <JP/US>
D02066 Isoproterenol sulfate (USP)
D02150 l-Isoprenaline hydrochloride (JP18) <JP>
|
R03CB02 Methoxyphenamine
|
R03CB03 Orciprenaline [DG:DG01044]
|
R03CB51 Isoprenaline, combinations
|
R03CB53 Orciprenaline, combinations
|
R03CC Selective beta-2-adrenoreceptor agonists
|
R03CK Adrenergics and other drugs for obstructive airway diseases
|
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
R05 COUGH AND COLD PREPARATIONS
|
R06 ANTIHISTAMINES FOR SYSTEMIC USE
|
R07 OTHER RESPIRATORY SYSTEM PRODUCTS
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|
Anatomical Therapeutic Chemical (ATC) Classification